Ryman Healthcare (ASX:RYM) Other Financing: A$883.7 Mil (TTM As of Mar. 2025)


ASX:RYM Ryman Healthcare Ltd ASX:RYM
53 GF Score
Price A$1.87
Valuation Possible Value Trap
View Full Analysis

What is Ryman Healthcare Other Financing?

Ryman Healthcare ASX:RYM 53 Other Financing is A$883.7 Mil as of Mar. 2025. GuruFocus rates ASX:RYM with a GF Score™ of 53/100 (Possible Value Trap).

Ryman Healthcare's Other Financing for the six months ended in Mar. 2025 was A$882.2 Mil.

Ryman Healthcare's Other Financing for the trailing twelve months (TTM) ended in Mar. 2025 was A$883.7 Mil.

Ryman Healthcare Other Financing Historical Data

* Premium members only.

The historical data trend for Ryman Healthcare's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ryman Healthcare Other Financing Chart

Ryman Healthcare Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.29 248.27 -798.48 -3.12 -3.89

Ryman Healthcare Semi-Annual Data
Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.61 -1.72 -1.39 1.53 882.19
ASX:RYM
53GF Score
Ryman Healthcare Ltd ASX:RYM
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ryman Healthcare Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$883.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of A$883.7 Mil mean?
Ryman Healthcare (ASX:RYM) has a Other Financing of A$883.7 Mil as of Mar. 2025. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Ryman Healthcare and its competitors.
Is Ryman Healthcare's Other Financing too high?
Ryman Healthcare's current Other Financing is A$883.7 Mil. Overall, Ryman Healthcare has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Ryman Healthcare's Other Financing compare to HCA and THC?
Ryman Healthcare's Other Financing of A$883.7 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Healthcare Providers & Services company?
A good Other Financing depends on the Healthcare Providers & Services industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Ryman Healthcare and its competitors. Ryman Healthcare's current Other Financing is A$883.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ryman Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Ryman Healthcare (ASX:RYM) is currently considered Possible Value Trap. The current Other Financing is A$883.7 Mil. Ryman Healthcare's overall GF Score™ is 53/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Ryman Healthcare (ASX:RYM), the current Other Financing is A$883.7 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ryman Healthcare Business Description

Other Exchanges RYM:New ZealandRH7:Germany
Address 92 Russley Road, P.O. Box 771, Christchurch, CT, NZL, 8042
Ryman Healthcare Ltd is a retirement living and aged care provider operating in New Zealand and Australia. It owns and operates integrated retirement villages through its trading subsidiaries, which operate in the aged care and retirement living sector in New Zealand and Australia. The Group operates in a single industry: the provision of integrated retirement living and aged care for older people in New Zealand and Australia. The majority of revenue is derived from Care and village fees, which relate to the provision of accommodation, care and related services to aged care residents and retirement living residents.
53GF Score

Get the complete analysis for ASX:RYM

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.87
Price